Option chain shows key data for Valneva's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Valneva.

Valneva (NASDAQ:VALN) Stock, Option Chain

VALNEVA SE - ADR

Valneva

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Gamestop, Lululemon, Uber, Ulta Beauty And Tesla: Why These 5 Stocks Are On Investors' Radars Today

News

Intraday Update

Markets

Movers

Trading Ideas

NNNN

SBAC

SKBL

VALN

Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday

bz_pharma_briefs

Biotech

Health Care

General

Valneva chikungunya vaccine shows strong, sustained immune response in adolescents, supporting potential approvals in Brazil and other regions.

Valneva Vaccine Shows Sustained Immune Response In Adolescents One Year After Single Shot

Accenture- AI Advantage

INOD

MESO

MVST

OMER

PRTA

SHCO

TRIP

Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday

Valneva SE

Contracts

Press Releases

Valneva Responds to French Government's Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion

Valneva Announces Filing of 2024 Universal Registration Document and US Form 20-F

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

Legal

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Valneva SE - VALN

Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program

Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA

Valneva's Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above

Small Cap

VALN Investors Have Opportunity to Join Valneva SE Fraud Investigation with the Schall Law Firm

PARIS:VLA

PARIS:VLAP

Akebia Therapeutics

AnaptysBio

ArriVent BioPharma

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

Bicara Therapeutics

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

Cogent Biosciences

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Gyre Therapeutics

Immunome

Immatics

KalVista Pharmaceuticals, Inc. - Common Stock

KalVista Pharma

Kura Oncology

LENZ Therapeutics

MeiraGTx Hldgs

Organogenesis Holdings

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

Prothena Corporation plc - Ordinary Shares

Prothena Corp

PureTech Health plc - American Depositary Shares

PureTech Health

Rocket Pharmaceuticals, Inc. - Common Stock

Rocket Pharmaceuticals

Replimune Group

Sionna Therapeutics

Savara

Xencor

HC Wainwright & Co.

Guggenheim

Comments

Valneva

Valneva (VALN) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga